相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
Ryota Masuzaki et al.
CANCERS (2022)
Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma
Laner Shi et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer
Mohamed Luban Sobah et al.
FRONTIERS IN MEDICINE (2021)
Inflammatory Mechanisms of HCC Development
Maria Grazia Refolo et al.
CANCERS (2020)
Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma
Md Gulam Musawwir Khan et al.
BMC CANCER (2020)
NLRP12 suppresses hepatocellular carcinoma via downregulation of cJun N-terminal kinase activation in the hepatocyte
S. M. Nashir Udden et al.
ELIFE (2019)
STAT3 and STAT5 Activation in Solid Cancers
Sebastian Igelmann et al.
CANCERS (2019)
Staging systems of hepatocellular carcinoma: A review
Sreeshma Tellapuri et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2018)
Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors
Lisa N. Heppler et al.
TRENDS IN CANCER (2017)
SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration
Ryota Masuzaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment
Qods Lahmar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
IL-6 pathway in the liver: From physiopathology to therapy
Dirk Schmidt-Arras et al.
JOURNAL OF HEPATOLOGY (2016)
The identification and characterization of a STAT5 gene signature in hematologic malignancies
Dmitriy Sonkin et al.
CANCER BIOMARKERS (2015)
Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer
E. Letellier et al.
BRITISH JOURNAL OF CANCER (2014)
SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer
Diego Iglesias-Gato et al.
CARCINOGENESIS (2014)
Histopathology of hepatocellular carcinoma
Manuel Schlageter et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis
Xinyu Qiu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease
Michael N. VanSaun et al.
PLOS ONE (2013)
Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
Giorgio Trinchieri
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice
Fahad Zadjali et al.
FASEB JOURNAL (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Tumor Promotion via Injury- and Death-Induced Inflammation
Ali Kuraishy et al.
IMMUNITY (2011)
Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
Kuen-Feng Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Suppressor of Cytokine Signaling-2 Gene Disruption Promotes ApcMin/+ Tumorigenesis and Activator Protein-1 Activation
Victoria A. Newton et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives
Ying-Chun Shen et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice
Kanji Yamaguchi et al.
LABORATORY INVESTIGATION (2010)
Experimental mouse models for hepatocellular carcinoma research
Femke Heindryckx et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation
Atsushi Hosui et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Experimental models of hepatocellular carcinoma
Philippa Newell et al.
JOURNAL OF HEPATOLOGY (2008)
Favorable prognostic value of SOCS2 and IGF-I in breast cancer
Michael C. Haffner et al.
BMC CANCER (2007)
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells
Neeraj K. Saxena et al.
CANCER RESEARCH (2007)
SOCS proteins, cytokine signalling and immune regulation
Akihiko Yoshimura et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Quantification of mRNA using real-time RT-PCR
Tania Nolan et al.
NATURE PROTOCOLS (2006)
Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence
SS Thorgeirsson et al.
HEPATOLOGY (2006)
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma
F Farabegoli et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells
S Fruchtman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer
EB Haura et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases
H Kamata et al.
CELL (2005)
SOCS2 negatively regulates growth hormone action in vitro and in vivo
CJ Greenhalgh et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism
B Schultheis et al.
BLOOD (2002)
Gigantism in mice lacking suppressor of cytokine signalling-2
D Metcalf et al.
NATURE (2000)
分享论文
